ZCJ-27670-73503
3 vaccinations
0 coded responses
12 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 641 / MO
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-16
Registered in v-safe
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-04-18
- 2021-04-25
- 2021-06-13
- 2021-09-12
-
2021-10-29
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-14
-
2022-09-09
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-16
- 2022-10-23
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Pfizer-BioNTech | Flu |
| 3 | 2022-09-09 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.